Connect Biopharma Holdings Limited — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$64K
R&D
$38M
D&A
$704K
Operating Income
$-58M
EBITDA
$-57M
Other Income/Expense
$3M
Pretax Income
$-55M
Tax Provision
$197K
Net Income
$-55M
Operating Margin
-90740.6%
Net Margin
-86687.5%
Effective Tax Rate
-0.4%
Tax Credit Carryforwards
$5M
NOL Carryforwards
$68M
ETR (Continuing Operations)
-0.3%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.0%
ETR Foreign Differential (pp)
-32.6%
Operating Lease Cost
$500K
Revenue YoY Variation
-99.8%
Income YoY Variation
-158.7%